Home › Funds › PERKINS CAPITAL MANAGEMENT INC › NMTC
PERKINS CAPITAL MANAGEMENT INC position in NMTC
NeuroOne Medical Technologies Corporat · Health Care
PERKINS CAPITAL MANAGEMENT INC reported holding 244,656 shares of NMTC (NeuroOne Medical Technologies Corporat) in its Q2 2026 13F filing — a position valued at US$744K, representing 0.56% of its reported portfolio and ranking #43 among its reported holdings. PERKINS CAPITAL MANAGEMENT INC has disclosed NMTC holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERKINS CAPITAL MANAGEMENT INC's NMTC position evolved
PERKINS CAPITAL MANAGEMENT INC first disclosed a stake in NMTC in Q3 2023 at 150,000 shares (US$134K). The position peaked in Q3 2025 at 1,468,000 shares, worth US$1.3M. Across 10 filings, PERKINS CAPITAL MANAGEMENT INC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 244,656 shares valued at US$744K — a reduction of -1,228,344 shares quarter over quarter.. Notable position changes include a 83% trim in Q2 2026 (shares fell 66% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 150.00K | $134.00K | New |
| Q4 2023 | 150.00K | $237.00K | Hold |
| Q1 2024 | 150.00K | $180.00K | Hold |
| Q2 2024 | 150.00K | $120.00K | Hold |
| Q3 2024 | 150.00K | $148.50K | Hold |
| Q2 2025 | 1.50M | $1.02M | New |
| Q3 2025 | 1.47M | $1.30M | Reduce |
| Q4 2025 | 1.47M | $1.12M | Hold |
| Q1 2026 | 1.47M | $1.14M | Hold |
| Q2 2026 | 244.66K | $743.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMTC and 13F data
NMTC (NeuroOne Medical Technologies Corporat) is a Health Care company. 28 other funds we track also report a position in NMTC — the largest reported positions include Bleichroeder LP (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on PERKINS CAPITAL MANAGEMENT INC
FAQ
How long has PERKINS CAPITAL MANAGEMENT INC held NMTC?
PERKINS CAPITAL MANAGEMENT INC has disclosed NMTC holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is PERKINS CAPITAL MANAGEMENT INC's current position in NMTC?
As of Q2 2026, PERKINS CAPITAL MANAGEMENT INC holds 244.66K shares of NMTC (NeuroOne Medical Technologies Corporat), valued at $743.75K, representing 0.56% of its reported portfolio and ranking #43.
Has PERKINS CAPITAL MANAGEMENT INC been buying or selling NMTC?
In the latest 13F filing (Q2 2026), PERKINS CAPITAL MANAGEMENT INC reduced its position in NMTC. The position peaked in Q3 2025 at 1.47M shares.
Which other funds hold NMTC?
Other major institutional holders of NMTC include Bleichroeder LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.